23andMe generates Revenue by selling Customer DNA Information to Big Pharma

January 9, 2015 12:09 PM

5 0

23andMe generates Revenue by selling Customer DNA Information to Big Pharma

23andMe, a privately held personal genomics and biotechnology company based in Mountain View, California, is generating its revenue from some other sources after US Food and Drug Administration asked the company to stop providing health-related information based on customer's DNA.

The company found a new way to deal with the issue. 23andMe has signed deals with pharmaceutical and biotech companies to sell customer DNA information for research and product development purposes.

Read more

To category page

Loading...